Biogen Inc. Common Stock
€169.43
EUR
Last updated on --.
24h volume892.76K
24h highest171.83 EUR
24h lowest166.93 EUR
24h Price movement+2.04%
BIIB recent prices
24 Hours
+2.04%+€3.388
30 days
+8.54%+€13.46
60 days
+6.12%+€9.865
90 days
+3.77%+€6.210
Key data
Previous close166.05 EUR
Market cap23.84B EUR
Volume892.76K
P/E ratio20.210000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)7.9894 EUR
Net income (FY)1.18B EUR
Revenue (FY)8.55B EUR
Last report dateApr 29, 2026
About Biogen Inc. Common Stock
HeadquartersCAMBRIDGE
Employees (FY)7.50K
Revenue per employee (FY)1.14M EUR
Net income per employee (FY)157.31K EUR
Listed onNasdaq
BIIB conversion tables
 |  |
|---|---|
| 0.5 BIIB | 84.71 EUR |
| 1 BIIB | 169.43 EUR |
| 5 BIIB | 847.18 EUR |
| 10 BIIB | 1,694.37 EUR |
| |
|---|---|
| 0.5 EUR | 0.0029509 BIIB |
| 1 EUR | 0.0059019 BIIB |
| 5 EUR | 0.029509 BIIB |
| 10 EUR | 0.059019 BIIB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BIIB is trading at €169.43, +2.04% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BIIB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BIIB is currently trading at €169.43, +2.04% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BIIB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BIIB's P/E ratio is currently 20.210000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BIIB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BIIB's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Biogen Inc. Common Stock's market cap is currently 23.84B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume892.76K
24h highest171.83 EUR
24h lowest166.93 EUR
24h Price movement+2.04%
Start trade with BIIB Perpetual
Sign up to trade